Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal

被引:15
|
作者
Meisel, Andreas [1 ]
Baggi, Fulvio [2 ]
Behin, Anthony [3 ]
Evoli, Amelia [4 ,5 ]
Kostera-Pruszczyk, Anna [6 ]
Mantegazza, Renato [2 ]
Morales, Raul Juntas [7 ]
Punga, Anna Rostedt [8 ]
Sacconi, Sabrina [9 ]
Schroeter, Michael [10 ]
Verschuuren, Jan [11 ]
Crathorne, Louise [12 ]
Holmes, Kris [12 ]
Leite, Maria-Isabel [13 ]
机构
[1] Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Integrated Myasthenia Gravis Ctr, Dept Neurol, Berlin, Germany
[2] Fdn Carlo Besta Neurol Inst, Neuroimmunol & Neuromuscular Dis Unit, Sci Inst Res & Hlth Care, Milan, Italy
[3] Hop La Pitie Salpetriere, Publ Hosp Network Paris, Inst Myol, Dept Neuromyol, Paris, France
[4] Univ Cattolica Sacro Cuore, Rome, Italy
[5] Agostino Gemelli Univ Polyclin Fdn, Sci Inst Res & Hlth Care, Rome, Italy
[6] Med Univ Warsaw, Dept Neurol, Warsaw, Poland
[7] Vall dHebron Univ Hosp, Neurol Dept, Barcelona, Spain
[8] Uppsala Univ, Dept Med Sci, Clin Neurophysiol, Uppsala, Sweden
[9] Nice Univ Hosp Ctr, Nice, France
[10] Univ Hosp Cologne, Dept Neurol, Cologne, Germany
[11] Leiden Univ, Med Ctr, Neurol, Leiden, Netherlands
[12] Prescript Commun, Letchworth, England
[13] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England
关键词
autoantibodies; biomarkers; myasthenia gravis; ANTIACETYLCHOLINE RECEPTOR ANTIBODY; ACETYLCHOLINE-RECEPTOR; DISEASE SEVERITY; TITIN-ANTIBODIES; PROTEIN; MUSK; ASSOCIATION;
D O I
10.1111/ene.15565
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose Although myasthenia gravis (MG) is recognized as an immunoglobulin G autoantibody-mediated disease, the relationship between autoantibody levels and disease activity in MG is unclear. We sought to evaluate this landscape through systematically assessing the evidence, testing the impact of predefined variables on any relationship, and augmenting with expert opinion. Methods In October 2020, a forum of leading clinicians and researchers in neurology from across Europe (Expert Forum for Rare Autoantibodies in Neurology in Myasthenia Gravis) participated in a series of virtual meetings that took place alongside the conduct of a systematic literature review (SLR). Results Forty-two studies were identified meeting inclusion criteria. Of these, 10 reported some correlation between a patient's autoantibody level and disease severity. Generally, decreased autoantibody levels (acetylcholine receptor, muscle-specific kinase, and titin) were positively and significantly correlated with improvements in disease severity (Quantitative Myasthenia Gravis score, Myasthenia Gravis Composite score, Myasthenia Gravis Activities of Daily Living score, Myasthenia Gravis Foundation of America classification). Given the limited evidence, testing the impact of predefined variables was not feasible. Conclusions This first SLR to assess whether a correlation exists between autoantibody levels and disease activity in patients with MG has indicated a potential positive correlation, which could have clinical implications in guiding treatment decisions. However, in light of the limited and variable evidence, we cannot currently recommend routine clinical use of autoantibody level testing in this context. For now, patient's characteristics, clinical disease course, and laboratory data (e.g., autoantibody status, thymus histology) should inform management, alongside patient-reported outcomes. We highlight the need for future studies to reach more definitive conclusions on this relationship.
引用
收藏
页码:266 / 282
页数:17
相关论文
共 50 条
  • [1] Reply to the Letter to the Editor in response to "Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal "
    Meisel, Andreas
    Baggi, Fulvio
    Behin, Anthony
    Evoli, Amelia
    Kostera-Pruszczyk, Anna
    Mantegazza, Renato
    Juntas Morales, Raul
    Punga, Anna Rostedt
    Sacconi, Sabrina
    Schroeter, Michael
    Verschuuren, Jan
    Crathorne, Louise
    Holmes, Kris
    Leite, Maria-Isabel
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (04) : 1162 - 1164
  • [2] Autoantibody levels as biomarkers of disease activity in the management of myasthenia gravis
    Li, Hai-Feng
    Gao, Feng
    Chen, Xiang-Jun
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (04) : 1160 - 1161
  • [3] Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management
    Lazaridis, Konstantinos
    Tzartos, Socrates J.
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [4] Myasthenia Gravis: A Systematic Review
    Mishra, Aneesh K.
    Varma, Anuj
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [5] Acupuncture for patients with myasthenia gravis A systematic review protocol
    Shi, Shuai
    Ji, Xinyu
    Wang, Yanping
    Liu, Bin
    Zhang, Huamin
    Lu, Cheng
    MEDICINE, 2019, 98 (42) : e17563
  • [6] Sleep disorders in patients with myasthenia gravis: a systematic review
    Oliveira, Ezequiel Fernandes
    Nacif, Sergio R.
    Pereira, Nixon Alves
    Fonseca, Nina Teixeira
    Urbano, Jessica Julioti
    Perez, Eduardo Araujo
    Cavalcante, Valeria
    Oliveira, Claudia Santos
    Insalaco, Giuseppe
    Oliveira, Acary Sousa Bulle
    Franco Oliveira, Luis Vicente
    JOURNAL OF PHYSICAL THERAPY SCIENCE, 2015, 27 (06) : 2013 - 2018
  • [7] A systematic review of polysomnographic variables in patients with myasthenia gravis
    Oliveira, E. F.
    Nacif, S.
    Urbano, J. J.
    Silva, A. S.
    Guimaraes, L. L.
    Oliveira, C. S.
    Perez, E. A.
    Polaro, M. N.
    Valerio, B. C. O.
    Stirbulov, R.
    Insalaco, G.
    Oliveira, A. S. B.
    Oliveira, L. V. F.
    JOURNAL OF SLEEP RESEARCH, 2016, 25 : 136 - 137
  • [8] The role of thymectomy in the treatment of juvenile myasthenia gravis: a systematic review
    Arin L. Madenci
    George Z. Li
    Brent R. Weil
    David Zurakowski
    Peter B. Kang
    Christopher B. Weldon
    Pediatric Surgery International, 2017, 33 : 683 - 694
  • [9] The role of thymectomy in the treatment of juvenile myasthenia gravis: a systematic review
    Madenci, Arin L.
    Li, George Z.
    Weil, Brent R.
    Zurakowski, David
    Kang, Peter B.
    Weldon, Christopher B.
    PEDIATRIC SURGERY INTERNATIONAL, 2017, 33 (06) : 683 - 694
  • [10] Dental management of patients with myasthenia gravis: A literature review
    Yarom, N
    Barnea, E
    Nissan, J
    Gorsky, M
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2005, 100 (02): : 158 - 163